About The Conference

About Conference

Cancer Therapeutics 2026

Cancer Therapeutics 2026International Conference on Cancer Therapeutics and Molecular Targets is a premier global scientific meeting dedicated to advancing innovative cancer treatments and improving patient outcomes. Scheduled for 2026 at an international venue, this conference is organized under the theme: “Transforming Cancer Care Through Molecular Targeting and Next-Generation Therapeutic Innovation.” Cancer Therapeutics 2026 provides a comprehensive and multidisciplinary platform to explore cutting-edge advancements in cancer biology, targeted therapies, immuno-oncology, precision medicine, and emerging treatment strategies. The conference brings together oncologists, cancer researchers, molecular biologists, clinicians, pharmaceutical scientists, academicians, and healthcare professionals from around the world to share knowledge, present groundbreaking research, and discuss evidence-based and translational approaches in cancer care.

What distinguishes Cancer Therapeutics 2026 is its integrated focus across the entire cancer treatment continuum—from molecular mechanisms and biomarker discovery to drug development, clinical trials, combination therapies, resistance mechanisms, survivorship, and personalized patient care—ensuring strong clinical relevance and real-world impact.

Why Attend Cancer Therapeutics 2026?

Cancer Therapeutics 2026 offers a unique opportunity to stay at the forefront of oncology innovation by engaging with global experts and the latest research developments. Attendees will benefit from:

  • In-depth insights into novel cancer therapeutics, targeted drugs, and immunotherapies
  • Updates on precision oncology, biomarkers, and personalized treatment strategies
  • Learning from renowned keynote speakers, international experts, and oncology thought leaders
  • Opportunities to present research through oral and poster sessions with global visibility
  • Extensive networking and collaboration opportunities with academic, clinical, and industry peers
  • Exposure to pharmaceutical innovations, biotechnology advancements, and emerging oncology pipelines

Who Can Attend?

Cancer Therapeutics 2026 is designed for a broad and diverse professional audience, including:

  • Medical, surgical, and radiation oncologists
  • Cancer researchers and translational scientists
  • Molecular biologists, geneticists, and bioinformaticians
  • Clinical researchers and clinical trial professionals
  • Pharmaceutical, biotechnology, and CRO professionals
  • Academicians, postgraduate students, and early-career researchers
  • Healthcare professionals, policymakers, and cancer care administrators

Key Benefits for Attendees

Participants of Cancer Therapeutics 2026 will gain:

  • Access to cutting-edge research and evidence-based cancer treatment strategies
  • Opportunities for interdisciplinary collaboration and global research partnerships
  • Engagement in interactive sessions, panel discussions, and expert-led workshops
  • Insights into emerging therapeutic platforms, drug development pathways, and market trends
  • Practical knowledge supporting improved clinical decision-making and patient-centered oncology care

Aim of the Conference

The primary aims of Cancer Therapeutics 2026 are to:

  • Foster global knowledge exchange and interdisciplinary collaboration in oncology
  • Bridge the gap between basic research, translational science, and clinical application
  • Promote innovations that enhance therapeutic precision, safety, and efficacy
  • Support the development of next-generation cancer therapies and personalized medicine
  • Contribute to improved survival rates, quality of life, and long-term patient outcomes

About Cognition Conferences

Cognition Conferences is a leading global scientific conference organization dedicated to advancing knowledge, research excellence, and innovation across a broad spectrum of academic, clinical, and technological disciplines. We have created a dynamic and inclusive international ecosystem that connects researchers, academicians, healthcare professionals, industry experts, policymakers, and students on a unified global platform.
Through thoughtfully designed scientific conferences, congresses, seminars, and workshops, Cognition Conferences highlights emerging research trends, translational breakthroughs, and real-world applications across diverse fields, including oncology and life sciences. Supported by a global network of advisory board members, keynote speakers, and subject matter experts, we facilitate impactful knowledge exchange, interdisciplinary dialogue, and meaningful collaboration.

Cognition Conferences fosters an intellectually stimulating and future-focused environment where participants can share discoveries, challenge existing paradigms, validate research outcomes, and explore new directions in science and medicine. By bringing together global leaders and emerging voices, we aim to shape future research agendas, address critical healthcare challenges, and support innovations that drive scientific excellence, sustainable development, and improved global health outcomes.

Register Now

Conference Starts In:

Cancer Therapeutics and Molecular Targets

00 Days
00 Hours
00 Minutes
00 Secs

About Conference

Conference Theme:

Transforming Cancer Care Through Molecular Targeting and Next-Generation Therapeutic Innovation

Abstract Submission Opens: January 5th, 2026
Early Bird Registration Start: January 26th, 2026
Date October 19-21, 2026
Venue Paris, France